Basic info
Industry
pharmaceutical manufacturing
Sectors
Biotechnology
Medical Foods
GI
Metabolic Formula
Nutrition
Protein Supplement
Cystic Fibrosis
Ketogenic Therapies
Glytactin containing GMP
Pharmaceutical
Inborn Errors of Metabolism
Nutritional Theraphy
Protein Allergy
Health Care
Glycomacropeptide
Therapeutics
Low Protein Foods
Intractable Epilesy
Medical Formula
Fitness
Date founded
2000
Funding rounds raised
C
Cambrooke raised undisclosed on April 11, 2016
Investors: van Galen, Seventure Partners and Ruffena Capital Ltd